The Peer Support Intervention - Supporting HIV Positive Adolescents in Zimbabwe to Improve HIV Care Continuum Outcomes
PESU
2 other identifiers
interventional
214
1 country
1
Brief Summary
Youth with evidence of virologic failure defined as an HIV VL\>400 copies/mL on two consecutive occasions at least 1 month apart will be eligible for enrollment. Youth will be randomized to a community based peer counseling support group or clinic based standard of care, with viral load, and drug monitoring evaluations at 3 month intervals to determine the efficacy of the intervention in improving adherence and virologic suppression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 11, 2016
CompletedFirst Posted
Study publicly available on registry
July 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedOctober 17, 2018
October 1, 2018
1.7 years
July 11, 2016
October 12, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Virologic suppression rate in the Peer Support Intervention i group compared with the standard of care group following 48 weeks in the Peer Support Intervention.
Virologic suppression
2 years
Secondary Outcomes (5)
Frequency of acquired drug resistance mutations among youth failing ART.
2 years
Baseline prevalence of psychological distress among adolescents and young adults failing first line therapy
2 years
Prevalence of psychological distress (measured using PHQ-A and SSQ) after 48 weeks of enrolment in the Peer Support Intervention compared with the standard of care
2 years
Association between self-reported adherence, pill counts and objective surrogate markers of adherence obtained from plasma (viral load), DBS and hair (tenofovir concentrations).
2 years
Effectiveness of point mutation assays for the detection of drug resistance as compared with standard sequencing techniques.
2 years
Study Arms (2)
Peer Support Intervention
EXPERIMENTALAdolescents/young adults in the Peer Support Intervention arm will be referred to a Peer Support Intervention support group within their own or nearby community. This support group will meet monthly and will be facilitated by a professional HIV counsellor together with a Peer Support Intervention counselor. The Peer Support Intervention counsellors will provide regular counselling to their allocated participants through home visits and SMS messages. Each participant will be visited once a week in their home. Whatsapp messages will be delivered daily to each participant by the Community Adolescent Treatment Supporters. The agreed messages will briefly enquire about the participant's well-being without specifically making reference to HIV or ARVs. In addition, participants' caregivers will be invited to a 3-session intervention to build knowledge, skills and confidence to better support their adolescents.
Standard of Care Practice
NO INTERVENTIONParticipants in the standard of care group will receive adherence evaluations and counseling at the clinic as per the current standard of care. Current procedures involve a group counseling session given on Monday morning during which topics are discussed that are relevant to adolescents. In general children aged between 13-19 years attend these sessions. After the group counseling, adolescents also receive an individual counseling session before being evaluated by the clinic doctor. Youth are also encouraged to complete a self reported adherence questionnaire and may periodically undergo pill counts by the clinic counselors. The adolescents may belong to peer support groups in their communities, however these activities are not part of the clinic program. No interventions are typically targeted at their caregivers.
Interventions
Eligibility Criteria
You may qualify if:
- Documented HIV positive
- Age \> 10 years and ≤ 24 years
- Two consecutive HIV VL\>400 copies/mL, at least one month apart
- Residence within 50 km of Harare
- Able to provide written informed consent (age 18 or older) or assent (age \<18 years)
You may not qualify if:
- Inability to provide informed consent or assent
- Past or current involvement in the Zvandiri Intervention Program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Parirenyatwa Hospital
Harare, 00263, Zimbabwe
Related Publications (2)
Mtisi TJ, Kouamou V, Morse GD, Dzinamarira T, Ndhlovu CE. Comparing pill counts and patient self-reports versus DBS tenofovir concentrations as ART adherence measurements with virologic outcomes and HIV drug resistance in a cohort of adolescents and young adults failing ART in Harare, Zimbabwe. J Infect Public Health. 2024 Sep;17(9):102500. doi: 10.1016/j.jiph.2024.102500. Epub 2024 Jul 17.
PMID: 39173560DERIVEDNdhlovu CE, Kouamou V, Nyamayaro P, Dougherty L, Willis N, Ojikutu BO, Makadzange AT. The transient effect of a peer support intervention to improve adherence among adolescents and young adults failing antiretroviral therapy in Harare, Zimbabwe: a randomized control trial. AIDS Res Ther. 2021 Jun 16;18(1):32. doi: 10.1186/s12981-021-00356-w.
PMID: 34134738DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Chiratidzo E Ndhlovu, MBChB
University of Zimbabwe College of Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
July 11, 2016
First Posted
July 14, 2016
Study Start
July 1, 2016
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
October 17, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share
Data is readily available and can be obtained following review by MRCZ as required in the consent forms.